Founders Grove Wealth Partners LLC Has $1.13 Million Stake in Procter & Gamble Company (The) $PG

Founders Grove Wealth Partners LLC lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 15.2% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,067 shares of the company’s stock after selling 1,270 shares during the period. Founders Grove Wealth Partners LLC’s holdings in Procter & Gamble were worth $1,126,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Morningstar Investment Management LLC bought a new position in shares of Procter & Gamble during the second quarter worth approximately $552,000. Harbour Trust & Investment Management Co increased its stake in shares of Procter & Gamble by 1.4% during the second quarter. Harbour Trust & Investment Management Co now owns 13,246 shares of the company’s stock worth $2,110,000 after purchasing an additional 177 shares during the period. RFG Advisory LLC increased its stake in shares of Procter & Gamble by 2.5% during the second quarter. RFG Advisory LLC now owns 43,568 shares of the company’s stock worth $6,941,000 after purchasing an additional 1,058 shares during the period. Perfromance Wealth Partners LLC increased its stake in shares of Procter & Gamble by 52.5% during the second quarter. Perfromance Wealth Partners LLC now owns 5,239 shares of the company’s stock worth $835,000 after purchasing an additional 1,803 shares during the period. Finally, Axxcess Wealth Management LLC raised its position in shares of Procter & Gamble by 0.3% in the second quarter. Axxcess Wealth Management LLC now owns 90,641 shares of the company’s stock valued at $14,441,000 after buying an additional 254 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

NYSE PG opened at $147.54 on Tuesday. The firm’s fifty day moving average price is $155.18 and its two-hundred day moving average price is $159.27. The stock has a market cap of $345.32 billion, a PE ratio of 22.66, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a fifty-two week low of $146.96 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Evercore ISI reiterated an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Wells Fargo & Company dropped their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Barclays dropped their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research report on Friday. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $172.21.

Insider Buying and Selling

In related news, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares of the company’s stock, valued at $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares in the company, valued at approximately $9,402,333.72. This represents a 4.97% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock valued at $23,421,279 over the last quarter. 0.20% of the stock is currently owned by company insiders.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.